martes, 30 de agosto de 2022

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge | NEJM

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge | NEJM

No hay comentarios:

Publicar un comentario